IDENTIFIED DATA TO RAPIDLY ACCESS PATIENTS
When it comes to data, both quantity and quality matter. With consented data for 100 million households, Biotech, Inc. can rapidly access detailed patient information by condition, age, gender, location and many other key variables.
Biotech, Inc. also has 20+ million identified patients in pre-screened databases, which provide granular eligibility data. This is a major asset for data-driven feasibility analyses, planning and actual enrollment.
Consented data for 100 million households
Database of approximately 20 million pre-screened, identified patients
MAKE DATA AN ADVANTAGE FOR YOUR TRIAL
Biotech, Inc.’s identified data instills your trials with greater predictability and less variation downstream, enabling greater budget certainty.
Likewise, speed is an asset, and meaningful data accelerates research conduct. With world-class statisticians and modeling technologies, Biotech, Inc. expertly sources and analyzes data to inform decisions. Biotech, Inc.’s technology also supports electronic medical record (EMR) validation.
Trust Biotech, Inc. to properly merge the logistical, academic and scientific aspects of data generation and analysis.